EPIGENETIC AGING OF THE OXIDATIVE STRESS RESPONSE IN THE MOUSE RPE
小鼠 RPE 氧化应激反应的表观遗传老化
基本信息
- 批准号:7986159
- 负责人:
- 金额:$ 61.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-30 至 2012-09-29
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Aging is the largest single risk factor for the development of complex genetic disease including cancer, autoimmune disease, and neurodegeneration (including age-related macular degeneration - AMD). The primary theory attempting to explain the role of aging in these diseases is focused on the macromolecular damage caused by reactive oxygen species (ROS) and the genetics of susceptibility to this damage. Complex genetic disease however can also be investigated from the perspective of epigenetics. Gene expression for many genes is epigenetically regulated as a function of age, and altered expression of these genes is potentially linked to the development and progression of disease. We hypothesize that age-related change in the expression of oxidative stress genes are the result of epigenetic changes in cytosine methylation in genomic DNA in the retinal pigment epithelium (RPE)/choroid. This type of methylation is the most common epigenetic modification of the genome. We will first measure the age-related change of the expression and cytosine methylation of a set of candidate genes in the mouse RPE/choroid which are linked to oxidative stress. The set includes Er1, Err1, Foxo3a, Nrf2, Pgc11, Prdx3, p66/Shc1, Sirt1, Sod2, Txn2, Txnrd2, and 14-3-38. Our preliminary data indicate that Prdx3, Sod2, and Txn2 may be epigenetically upregulated as a function of age. Next we will validate these results for SOD2 in the human RPE using fresh frozen and/or paraffin embedded tissue. The significance of this work is the development of a new approach to understanding the age-related risk for complex genetic disease in the retinal pigment epithelium. This approach will yield new targets for drug development and potential treatments which may enhance our current management of age-related macular degeneration (AMD).
PUBLIC HEALTH RELEVANCE: This proposal outlines research on the epigenetics of age-related changes in the oxidative stress response in the mouse and human retinal pigment epithelium. The goal is to identify genes that may also be epigenetically regulated in human age-related retinal degeneration. The significance of this work is to provide a deeper understanding of how age is related to retinal degeneration, and the identification of new targets for drug development. This work will eventually lead to the development of individualized treatments for blinding eye diseases.
描述(由申请人提供):衰老是开发复杂遗传疾病(包括癌症,自身免疫性疾病和神经变性的)最大的单一危险因素(包括与年龄相关的黄斑变性-AMD)。试图解释衰老在这些疾病中的作用的主要理论集中于由活性氧(ROS)引起的大分子损害以及对这种损害的易感性的遗传学。然而,复杂的遗传疾病也可以从表观遗传学的角度研究。许多基因的基因表达在表观遗传学上是根据年龄的函数的,这些基因的表达改变可能与疾病的发展和进展有关。我们假设与年龄相关的氧化应激基因表达变化是视网膜色素上皮(RPE)/脉络膜中基因组DNA中胞嘧啶甲基化的表观遗传变化的结果。这种类型的甲基化是基因组最常见的表观遗传学修饰。我们将首先测量与氧化应激有关的小鼠RPE/脉络膜中一组候选基因表达和胞嘧啶甲基化的变化。该集合包括ER1,ERR1,FOXO3A,NRF2,PGC11,PRDX3,P66/SHC1,SIRT1,SOD2,TXN2,TXNRD2,TXNRD2和14-3-38。我们的初步数据表明,PRDX3,SOD2和TXN2可以表观上上调,这是年龄的函数。接下来,我们将使用新鲜的冷冻和/或石蜡嵌入的组织来验证人RPE中的SOD2。这项工作的意义是开发一种新方法,以了解视网膜色素上皮中复杂遗传疾病的年龄相关风险。这种方法将为药物开发和潜在治疗带来新的靶标,这可能会增强我们目前对年龄相关的黄斑变性(AMD)的管理。
公共卫生相关性:该提案概述了小鼠和人类视网膜色素上皮氧化应激反应变化的表观遗传学的研究。目的是确定在与人类年龄相关的视网膜变性中也可能在表观遗传调节的基因。这项工作的意义是对年龄与视网膜变性的关系以及对药物开发的新目标的识别提供更深入的了解。这项工作最终将导致开发针对盲目疾病的个性化治疗方法。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Potential therapeutic approaches for modulating expression and accumulation of defective lamin A in laminopathies and age-related diseases.
- DOI:10.1007/s00109-012-0962-4
- 发表时间:2012-12
- 期刊:
- 影响因子:4.7
- 作者:Zhavoronkov, Alex;Smit-McBride, Zeljka;Guinan, Kieran J.;Litovchenko, Maria;Moskalev, Alexey
- 通讯作者:Moskalev, Alexey
共 1 条
- 1
Leonard Martin Hje...的其他基金
Epigenetic regulation of SOD2 and CFH gene expression in the aging RPE
衰老 RPE 中 SOD2 和 CFH 基因表达的表观遗传调控
- 批准号:85383988538398
- 财政年份:2011
- 资助金额:$ 61.75万$ 61.75万
- 项目类别:
Epigenetic regulation of SOD2 and CFH gene expression in the aging RPE
衰老 RPE 中 SOD2 和 CFH 基因表达的表观遗传调控
- 批准号:83286818328681
- 财政年份:2011
- 资助金额:$ 61.75万$ 61.75万
- 项目类别:
Epigenetic regulation of SOD2 and CFH gene expression in the aging RPE
衰老 RPE 中 SOD2 和 CFH 基因表达的表观遗传调控
- 批准号:80859508085950
- 财政年份:2011
- 资助金额:$ 61.75万$ 61.75万
- 项目类别:
Age-related epigenetic gene silencing in the RPE
RPE 中与年龄相关的表观遗传基因沉默
- 批准号:71385057138505
- 财政年份:2006
- 资助金额:$ 61.75万$ 61.75万
- 项目类别:
Age-related epigenetic gene silencing in the RPE
RPE 中与年龄相关的表观遗传基因沉默
- 批准号:72700997270099
- 财政年份:2006
- 资助金额:$ 61.75万$ 61.75万
- 项目类别:
REDOX CONTROL OF FGF GENE EXPRESSION IN AGING RPE
衰老 RPE 中 FGF 基因表达的氧化还原控制
- 批准号:63845306384530
- 财政年份:1986
- 资助金额:$ 61.75万$ 61.75万
- 项目类别:
BIOCHEMICAL MODULATION OF RETINAL GLIOSIS
视网膜胶质细胞增生的生化调节
- 批准号:32626553262655
- 财政年份:1986
- 资助金额:$ 61.75万$ 61.75万
- 项目类别:
BIOCHEMICAL MODULATION OF RETINAL GLIOSIS
视网膜胶质细胞增生的生化调节
- 批准号:32626563262656
- 财政年份:1986
- 资助金额:$ 61.75万$ 61.75万
- 项目类别:
REGULATION OF FGF EXPRESSION DURING RETINAL DETACHMENT
视网膜脱离过程中 FGF 表达的调节
- 批准号:32626543262654
- 财政年份:1986
- 资助金额:$ 61.75万$ 61.75万
- 项目类别:
REGULATION OF FGF EXPRESSION DURING RETINAL DETACHMENT
视网膜脱离过程中 FGF 表达的调节
- 批准号:27109202710920
- 财政年份:1986
- 资助金额:$ 61.75万$ 61.75万
- 项目类别:
相似国自然基金
基于计算生物学技术小分子农兽药残留物驼源单域抗体虚拟筛选与亲和力成熟 -以内蒙古阿拉善双峰驼为例
- 批准号:32360190
- 批准年份:2023
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于胞内蛋白亲和力标记策略进行新型抗类风湿性关节炎的选择性OGG1小分子抑制剂的发现
- 批准号:82304698
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于多尺度表征和跨模态语义匹配的药物-靶标结合亲和力预测方法研究
- 批准号:62302456
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
框架核酸多价人工抗体增强靶细胞亲和力用于耐药性肿瘤治疗
- 批准号:32301185
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
抗原非特异性B细胞进入生发中心并实现亲和力成熟的潜力与调控机制
- 批准号:32370941
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
The role of extracellular vesicles in keratoconus pathogenesis
细胞外囊泡在圆锥角膜发病机制中的作用
- 批准号:1059512110595121
- 财政年份:2023
- 资助金额:$ 61.75万$ 61.75万
- 项目类别:
Regulators of Photoreceptor Aerobic Glycolysis in Retinal Health and Disease
视网膜健康和疾病中光感受器有氧糖酵解的调节因子
- 批准号:1071782510717825
- 财政年份:2023
- 资助金额:$ 61.75万$ 61.75万
- 项目类别:
Quantifying proteins in plasma do democratize personalized medicine for patients with type 1 diabetes
量化血浆中的蛋白质确实使 1 型糖尿病患者的个性化医疗民主化
- 批准号:1073028410730284
- 财政年份:2023
- 资助金额:$ 61.75万$ 61.75万
- 项目类别:
Characterizing molecular phenotypes of pancreatic islet reactive B cells in T1D through single cell sequencing
通过单细胞测序表征 T1D 中胰岛反应性 B 细胞的分子表型
- 批准号:1060051010600510
- 财政年份:2023
- 资助金额:$ 61.75万$ 61.75万
- 项目类别:
Protease-activated-receptor-2 antagonists for treatment of migraine pain
蛋白酶激活受体 2 拮抗剂治疗偏头痛
- 批准号:1060282610602826
- 财政年份:2023
- 资助金额:$ 61.75万$ 61.75万
- 项目类别: